Article PDF
Avoid common mistakes on your manuscript.
References
Benfield P, Ward A (1986) Fluvoxamine a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32: 313–334
Claasen V (1983) Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br J Clin Pharmacol 15: 349S-355
Meador-Woodruff J, Akil M, Wisner-Carlson R, Grunhaus L (1988) Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels. J Clin Psychopharmacol 8: 28–32
Rudorfer MW, Potter WZ (1987) Pharmacokinetics of antidepressants. In: Meltzer HY (ed) Psychopharmacology, the third generation of progress. Raven Press, New York, pp 1353–1363
Vandel B, Vandel S, Allers G, Bechtel P, Volmat R (1979) Interaction between amitriptyline and phenothiazines in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response. Psychopharmacology 65: 187–190
Vandel B, Vandel S, Jounet JM, Allers G, Volmat R (1982) Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response. Eur J Clin Pharmacol 22: 15–20
Vandel S, Bertschy G, Jounet JM, Allers G (1988) Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients. Ther Drug Monit 10: 386–389
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bertschy, G., Vandel, S., Vandel, B. et al. Fluvoxamine-tricyclic antidepressant interaction. Eur J Clin Pharmacol 40, 119–120 (1991). https://doi.org/10.1007/BF00315151
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315151